Latest
NANTONG, CHINA - FEBRUARY 27 2020: Employees work on the production line of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media.
10 hours ago
FDA Gives Emergency Authorization To Potential COVID-19 Drugs, But Doubts Remain
10 hours ago
Life on a Block With an Emergency Morgue Truck: ‘We Hear the Hum of the Refrigerator Going All Night Long’
10 hours ago
Census Tweaks Its 2020 Count Plans Due To The Pandemic

John Birch Society at CPAC

By
|
February 19, 2010 6:51 p.m.
EDITORS' NOTE: TPM is making our COVID-19 coverage free to all readers during this national health crisis. If you’d like to support TPM's reporters, editors and staff, the best way to do so is to become a member.

One of the hallmarks of post-Buckley, Movement Conservatism has always been the conscious exclusion of the John Birch Society as an extremist group. But at this weekend’s CPAC conference they were finally allowed in. Here’s John Birch Society President John F. McManus, at the Society’s sponsor table.

image content

Key Coronavirus Crisis Links

Josh Marshall’s Twitter List of Trusted Experts (Epidemiologists, Researchers, Clinicians, Journalists, Government Agencies) providing reliable real-time information on the COVID-19 Crisis.

Johns Hopkins Global COVID-19 Survey (most up to date numbers globally and for countries around the world).

COVID-19 Tracking Project (updated data on testing and infections in the U.S.).

Worldometers.info (extensive source of information and data visualizations on COVID-19 Crisis — discussion of data here).

Author Headshot
Josh Marshall (@joshtpm)  is editor and publisher of TPM.
 Have a tip? Send it Here!
More In Edblog
advertisement
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Senior Editor:
Special Projects Editor:
Investigations Desk:
Reporters:
Newswriters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Publishing Associate:
Front-End Developer:
Senior Designer: